Tema Oncology ETF Rating $24.54 -0.10 (-0.39%) As of 03/28/2025 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Oncology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CANC Aggregate RatingModerate Buy 2.83Holdings in CANC have an aggregate rating of Moderate Buy based on 638 analyst ratings issued in the past year covering 47 companies (85.1% of the portfolio).CANC Aggregate Price Target$24.53High Prediction$24.53Average Prediction$24.53Low Prediction$24.53Holdings in CANC have an aggregate price target of $24.53 and a range of $24.53 to $24.53 covering 47 companies (85.1% of the portfolio).CANC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy19 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Oncology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 47 CANC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.26%LLYEli Lilly and Company$820.30-0.2%4.8015 of 5 stars2.85$1,009.72 23.1%20Positive News5.20%RHHBYRoche$41.92-1.0%N/A2.506Short Interest ↓5.07%RVMDRevolution Medicines$37.35-2.0%4.1315 of 5 stars3.08$66.31 77.5%13Positive News4.43%BMYBristol-Myers Squibb$60.10+2.0%3.8843 of 5 stars2.32$57.86 -3.7%19Options VolumeNews CoveragePositive News3.96%EXELExelixis$36.70-0.4%4.5269 of 5 stars2.50$37.59 2.4%20Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoveragePositive News3.91%NUVLNuvalent$73.05-0.8%2.2264 of 5 stars2.92$113.10 54.8%13Positive News3.88%BBIOBridgeBio Pharma$35.11-3.5%4.5948 of 5 stars2.91$52.90 50.7%11Insider TradeNews Coverage3.20%MRUSMerus$44.61-0.5%2.1676 of 5 stars3.13$85.31 91.2%16Analyst Forecast3.12%ONCBeigene$267.39+1.8%1.4657 of 5 stars3.00$310.00 15.9%33.11%GMABGenmab A/S$19.90-1.2%4.0165 of 5 stars2.77$41.33 107.7%13Short Interest ↑Gap Down3.03%ACLXArcellx$67.96-0.8%2.3003 of 5 stars3.13$108.46 59.6%15Positive News2.96%MRKMerck & Co., Inc.$89.18+1.8%5 of 5 stars2.65$117.12 31.3%232.96%LEGNLegend Biotech$35.06-0.9%2.8557 of 5 stars2.92$79.00 125.3%12Short Interest ↓Positive News2.95%SMMTSummit Therapeutics$20.32-1.4%2.8129 of 5 stars3.00$35.44 74.4%10Analyst Upgrade2.91%AMGNAmgen$306.95+0.4%4.4347 of 5 stars2.48$314.04 2.3%23Analyst UpgradePositive News2.83%BPMCBlueprint Medicines$88.72-1.1%2.7851 of 5 stars2.70$124.95 40.8%23Insider TradePositive News2.12%JANXJanux Therapeutics$29.10-2.3%2.6506 of 5 stars3.08$92.44 217.7%12Positive News2.10%ABBVAbbVie$205.12+1.2%4.5213 of 5 stars2.92$211.45 3.1%25Positive News2.01%ZLABZai Lab$37.29+3.1%2.384 of 5 stars2.75$47.37 27.0%4Analyst ForecastGap UpHigh Trading Volume1.88%ARGXargenx$589.15-0.7%3.2447 of 5 stars2.91$687.00 16.6%23Positive News1.76%GILDGilead Sciences$111.79+0.6%4.5821 of 5 stars2.72$105.12 -6.0%29Analyst ForecastPositive News1.29%IDYAIDEAYA Biosciences$17.05-2.2%3.5791 of 5 stars2.93$53.58 214.3%15News CoveragePositive News1.10%REGNRegeneron Pharmaceuticals$637.36+0.2%4.8248 of 5 stars2.76$973.13 52.7%25Short Interest ↑Positive News1.02%MREOMereo BioPharma Group$2.30-4.6%2.1978 of 5 stars3.25$7.71 235.4%8Earnings ReportAnalyst ForecastNews CoveragePositive News0.99%DAWNDay One Biopharmaceuticals$8.07-1.5%2.925 of 5 stars3.13$32.29 300.1%8Analyst Forecast0.94%CGONCG Oncology$26.42-1.9%1.1881 of 5 stars3.10$63.88 141.8%10Earnings ReportAnalyst ForecastNews Coverage0.92%NRIXNurix Therapeutics$12.15-3.2%2.028 of 5 stars2.83$30.88 154.2%180.79%COGTCogent Biosciences$6.48-2.0%2.38 of 5 stars2.75$14.43 122.7%8Positive News0.70%GHGuardant Health$43.14-4.5%4.2613 of 5 stars3.00$48.95 13.5%20Analyst ForecastNews Coverage0.70%INCYIncyte$60.60-0.1%4.6784 of 5 stars2.21$74.88 23.6%19Positive News0.67%LNTHLantheus$96.16-0.9%4.2597 of 5 stars3.00$129.43 34.6%70.66%IMCRImmunocore$29.58-1.8%1.9272 of 5 stars2.54$65.64 121.9%130.64%REPLReplimune Group$10.39-0.6%3.8131 of 5 stars3.13$19.43 87.0%8Positive News0.63%ZYMEZymeworks$12.37-1.1%2.6199 of 5 stars2.88$21.00 69.8%8Insider TradePositive News0.57%EXASExact Sciences$43.66-3.0%4.4935 of 5 stars2.90$70.26 60.9%21Analyst ForecastNews CoveragePositive News0.56%SDGRSchrödinger$19.96-1.5%2.6114 of 5 stars3.00$32.29 61.8%8Positive NewsGap Up0.51%CGEMCullinan Therapeutics$8.02-3.3%2.1563 of 5 stars3.00$32.86 309.7%8Positive News0.49%ELVNEnliven Therapeutics$21.07-2.0%2.6515 of 5 stars3.20$38.75 83.9%5News Coverage0.47%ARVNArvinas$7.59-5.6%3.6351 of 5 stars2.67$35.50 367.7%15Short Interest ↓High Trading Volume0.46%ORICORIC Pharmaceuticals$6.14-2.4%4.0834 of 5 stars3.00$18.86 207.1%90.45%ILMNIllumina$80.00-2.8%4.7706 of 5 stars2.48$140.90 76.1%210.44%RLAYRelay Therapeutics$2.72-9.0%2.2494 of 5 stars2.90$19.80 627.9%10News Coverage0.41%SNDXSyndax Pharmaceuticals$13.18-2.8%3.6389 of 5 stars2.90$36.20 174.7%100.32%AUTLAutolus Therapeutics$1.66+0.6%2.7965 of 5 stars3.00$9.52 473.5%60.27%IOVAIovance Biotherapeutics$3.56-1.9%4.2901 of 5 stars2.88$20.25 468.8%80.25%CELCCelcuity$10.24-2.8%1.6951 of 5 stars3.14$30.17 194.6%7Upcoming Earnings0.21%RCUSArcus Biosciences$8.17-3.8%2.2474 of 5 stars3.00$30.25 270.5%10Gap Down This page (NASDAQ:CANC) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CANC Stock Free CANC Stock Alerts